SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: corporal spewchunks who wrote (5672)11/16/1998 2:43:00 PM
From: Biomaven  Read Replies (2) | Respond to of 6136
 
IL-2 and HAART:

Reports today that Interleukin-2 may flush out the resting T cells and enable HAART to get at them:

cnn.com

Note that CHIR is already running some IL-2 monotherapy trials:

thebody.com

I bought a few more CHIR calls today.

Peter